Full-Time

Safety & PV Specialist 1

Mandarin/Chinese Speaker

Syneos Health

Syneos Health

10,001+ employees

Global provider of integrated clinical-to-commercial services

No salary listed

Remote in India

Remote

Category
Biology & Biotech (2)
,
Required Skills
Visio
Requirements
  • Bachelor’s degree in Life Sciences, Nursing, Pharmacy, or an equivalent combination of education and experience providing the knowledge, skills, and abilities required for the role.
  • Science graduates preferred; fresher candidates are welcome.
  • Prior experience in Pharmacovigilance/Drug Safety is a plus.
  • Mandarin/Chinese Proficiency: HSK 4 minimum; HSK 5+ preferred
  • Writing: Critical
  • Speaking: Conversational level acceptable
  • Translating: Highly important
  • Experience with Safety Database systems and knowledge of medical terminology
  • Understanding of clinical trial processes (Phases II–IV) and/or post-marketing safety requirements, including ICH GCP, GVP, and related regulations
  • Proficient in MS Office (Word, Excel, PowerPoint), Visio, Outlook, Team Share, and internet tools
  • Ability to work independently and in a team environment
  • Excellent communication, interpersonal, and organizational skills
  • Detail-oriented with high accuracy and ability to meet deadlines
  • Shift Timings: Tuesday to Saturday, 3 PM – 12 AM (night); Flexibility may be required based on business needs; shift extensions may be necessary
Responsibilities
  • Enter information into PVG quality and tracking systems for receipt and tracking ICSR as required.
  • Assists in the processing of ICSRs according to Standard Operating Procedures (SOPs) and project/program-specific safety plans as required.
  • Triages ICSRs, evaluates ICSR data for completeness, accuracy, and regulatory report ability.
  • Enters data into safety database.
  • Codes events, medical history, concomitant medications, and tests.
  • Compiles complete narrative summaries.
  • Identifies information to be queried and follows up until information is obtained and queries are satisfactorily resolved.
  • Assists in the generation of timely, consistent, and accurate reporting of expedited reports in accordance with applicable regulatory requirements.
  • Maintains safety tracking for assigned activities.
  • Performs literature screening and review for safety, drug coding, maintenance of drug dictionary, MedDRA coding as required.
  • Validation and Submission of xEVMPD product records, including appropriate coding of indication terms using MedDRA.
  • Manual recoding of un-recoded product and substance terms arises from ICSRs.
  • Identification and management of duplicate ICSRs.
  • Activities related to SPOR / IDMP.
  • Quality review of ICSRs.
  • Ensures all relevant documents are submitted to the Trial Master File (TMF) as per company SOP/Sponsor requirements for clinical trials and the Pharmacovigilance System Master File for post-marketing programs as appropriate.
  • Maintains understanding and compliance with SOPs, Work Instructions (WIs), global drug/biologic/device regulations, GCP, ICH guidelines, GVP, project/program plans and the drug development process.
  • Fosters constructive and professional working relationships with all project team members, internal and external.
  • Participates in audits as required/appropriate.
  • Applies safety reporting regulatory intelligence maintained by Syneos Health to all safety reporting activities.

Syneos Health provides end-to-end biopharmaceutical solutions across the clinical-to-commercial spectrum. It helps biopharma companies, healthcare organizations, and investors by offering specialized expertise, insights, and technology-enabled services to move therapies faster to patients. Its offerings include Kinetic, a modern omnichannel customer engagement platform that uses targeting and analytics to coordinate nationwide healthcare communications, and Syneos One, an asset development approach that aligns strategy and execution from early concept through commercialization. The company uses AI and advanced tech to improve performance and reduce risk in drug development and market delivery. Its goal is to be a trusted partner that accelerates therapy development and delivery by combining scientific know-how with integrated, data-driven services.

Company Size

10,001+

Company Stage

IPO

Headquarters

Morrisville, North Carolina

Founded

1985

Simplify Jobs

Simplify's Take

What believers are saying

  • KAI Conversations partnership embeds AI conversation intelligence into commercial solutions since April 2026.
  • Bestudy acquisition secures foothold in China's rapidly growing biopharma market.
  • Sunway Healthcare partnership expands clinical trial expertise across Malaysia's therapeutic areas.

What critics are saying

  • Securities class action advances to discovery after March 2026 court denial in SDNY.
  • Abandoning 2016 NC jobs grant triggers government clawbacks within 6-12 months.
  • China Bestudy acquisition halts trials from CFDA inspections in 12-18 months.

What makes Syneos Health unique

  • Syneos Health integrates clinical, real-world evidence, and commercial strategy for end-to-end biopharma solutions.
  • Kinetic platform delivers AI-powered omnichannel customer engagement for healthcare organizations.
  • Syneos One methodology combines asset strategy and execution from concept to commercialization.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Syneos Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Employee Stock Purchase Plan

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Remote Work Options

Company News

Fierce Biotech
Mar 19th, 2026
Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’

North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. | North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. Syneos has acquired Chinese CRO Bestudy to secure a foothold in the Asian nation.

PRWeek
May 7th, 2025
Imre hires Greg Voyles as chief growth officer

Voyles joins Imre from Syneos Health, where he served as VP of commercial solutions.

Healthcare Asia Magazine
Dec 2nd, 2024
Sunway Healthcare Group, Syneos Health to expand clinical trial expertise

Sunway Healthcare Group has partnered with Syneos Health to expand clinical trial capabilities across therapeutic areas in Malaysia.

BioSpace
Oct 10th, 2024
Syneos Health Appoints Costa Panagos as Chief Executive Officer

Syneos Health appoints Costa Panagos as chief executive officer.

PRWeek
Oct 7th, 2024
Syneos Health makes senior hires

Syneos has also appointed Jen Husdan as an associate director.